Getinge (GETI B.ST) Saham Harga
Getinge Harga
Pendapatan tumbuh 5,3% per tahun selama 19 tahun terakhir menjadi 34,97 miliar SEK. Laba per saham tumbuh 3,1% per tahun selama 19 tahun terakhir. margin bersih Getinge saat ini 6,5%, turun dari 11,0% beberapa tahun lalu. Getinge saat ini menawarkan imbal hasil dividen sekitar 1,72%. Rasio pembayaran sekitar 55% dari laba. Dividen tumbuh 4,7% per tahun selama 19 tahun terakhir. Target harga median analis adalah 231,03 SEK, di bawah harga saat ini sebesar 13,8%. Dari 14 analis, 8 merekomendasikan beli — konsensus keseluruhan Beli.
Harga saham Getinge
Akses data ini lewat Eulerpool API
100.000 permintaan/bulan gratis · tanpa kartu
Model bisnis dan analisis saham Getinge
Pertanyaan yang sering diajukan tentang saham Getinge
Getinge AB is a global medical technology company that specializes in providing solutions for hospitals and healthcare organizations. The business model of Getinge AB revolves around offering innovative products, systems, and services within areas such as surgical workflows, patient care, and infection control. They strive to improve patient outcomes and enable healthcare professionals to deliver efficient and safe care. With a focus on providing high-quality medical equipment and integrated solutions, Getinge AB aims to enhance the overall healthcare experience.
Getinge AB is primarily active in the healthcare industry.
The main competitors of Getinge AB in the market include leading medical technology companies such as Medtronic, Johnson & Johnson, and Siemens Healthineers. These companies also provide a wide range of innovative medical devices and solutions, competing with Getinge AB in areas such as surgical equipment, patient handling systems, and infection control products. Getinge AB, as a global provider of medical technology, faces intense competition in its quest to deliver advanced healthcare solutions to customers worldwide.
Getinge AB, a renowned Swedish company, has a rich history and a strong background in the healthcare industry. Established in 1904, Getinge has evolved into a global leader in medical technology, providing innovative solutions for infection control and surgical workflows. With a primary focus on improving patient outcomes and enhancing healthcare efficiency, Getinge offers a wide range of products and services, including advanced medical equipment, such as surgical tables, anesthesia systems, and sterilization equipment. Over the years, Getinge has expanded its operations internationally, becoming a trusted partner for healthcare institutions worldwide. Through continuous innovation and dedication to healthcare excellence, Getinge AB has firmly established itself as a leading player in the global medical technology market.
Getinge AB has achieved several significant milestones throughout its history. One major accomplishment was the acquisition of Maquet in 2000, which expanded the company's portfolio and global reach. In 2006, Getinge AB successfully listed its shares on the Stockholm Stock Exchange, strengthening its position in the market. The company has also made substantial progress in research and development, introducing innovative medical technology solutions for healthcare professionals worldwide. Additionally, Getinge AB has focused on sustainability initiatives, committing to reducing its carbon footprint and promoting environmentally friendly practices. These milestones demonstrate Getinge AB's commitment to growth, innovation, and sustainability in the healthcare industry.
Getinge AB, a renowned global medical technology company based in Sweden, operates in multiple countries and regions worldwide. With a strong international presence, Getinge AB extends its operations across various continents, including Europe, Asia, North America, and Latin America. The company establishes its footprint in countries such as Sweden, Germany, France, the United States, China, Brazil, and many more. Through its extensive network and subsidiaries, Getinge AB serves customers across the globe, contributing to the advancement of healthcare and improving patient outcomes.
Getinge AB is committed to upholding certain values and corporate philosophy. The company believes in promoting patient safety and enhancing healthcare outcomes. They prioritize quality in their products and services, ensuring efficient and reliable medical solutions. Getinge AB strives for sustainability by minimizing the environmental impact of their operations and products. They value transparency, integrity, and accountability in their business practices. Getinge AB consistently focuses on innovation and advancement in the healthcare industry, aiming to improve patients' lives worldwide. With their dedication to their mission and values, Getinge AB continues to be a trusted and influential player in the medical technology sector.
Analis saat ini menetapkan target harga rata-rata 238,81 SEK untuk saham Getinge (median: 231,03 SEK), yaitu -10,8 % terhadap harga terbaru. Konsensus didasarkan pada 14 peringkat analis.
14 analis saat ini menilai saham Getinge: 8 merekomendasikan beli, 5 tahan, dan 1 jual. Untuk 2026, analis memperkirakan Getinge menghasilkan pendapatan 35,26 miliar SEK dan laba per saham 12,89 SEK.
Dengan kurs saat ini, saham Getinge diperdagangkan pada 24,08 EUR (268,00 SEK).
Saham Getinge (GETI B.ST) tercatat di 9 bursa, termasuk: London (0GZV.L), SIX (Zürich) (GETIB.SW), Frankfurt (GTN.F), München (GTN.MU), Düsseldorf (GTN.DU), Stockholm (GETI B.ST).
Getinge AB is a Swedish company specializing in the manufacturing of medical devices and solutions. The company operates in three main areas: Acute Care Therapies, Life Science, and Surgical Workflows. Getinge offers products and services to improve patient care and enhance the efficiency and profitability of hospitals and medical facilities. They provide solutions for critical care situations, infection prevention and control, as well as for the life sciences, pharmaceutical, and food industries. Getinge also offers products and solutions for surgical workflows, including cleaning, disinfection, sterilization, and training services. The company follows a value-based healthcare model, aiming to provide value to customers by ensuring optimal patient treatment and economic responsibility. With a focus on continuous innovation, Getinge strives to meet the evolving needs of its customers as a global leader in the medical technology industry.
Pendapatan diperkirakan dari Getinge adalah 35,26 miliar SEK. Angka ini didasarkan pada data keuangan terkini dan mencerminkan kinerja bisnis perusahaan.
Laba diperkirakan dari Getinge adalah 3,51 miliar SEK. Laba bersih mencerminkan profitabilitas perusahaan setelah mengurangi semua biaya.
Rasio harga-terhadap-pendapatan (PER) Getinge saat ini adalah 20,80. PER membandingkan harga saham saat ini dengan laba per saham dan membantu investor menilai valuasi saham Getinge.
Rasio harga-terhadap-penjualan (PSR) Getinge saat ini adalah 2,07. PSR membandingkan kapitalisasi pasar dengan pendapatan tahunan dan berfungsi sebagai metrik valuasi untuk saham Getinge.
Skor Kualitas AlleAktien untuk Getinge adalah 4/10.
ISIN dari Getinge adalah SE0000202624. ISIN (International Securities Identification Number) adalah identifikasi unik global untuk sekuritas.
WKN dari Getinge adalah 889714. WKN (Wertpapierkennnummer) adalah kode identifikasi sekuritas Jerman enam digit.
Ticker dari Getinge adalah GETI B.ST. Simbol ticker digunakan untuk memperdagangkan saham Getinge di bursa saham.
Saham Getinge
Kelompok Peer Getinge
Getinge Ticker
Getinge FIGI
Semua metrik fundamental dan analisis mendalam Getinge
Analisis saham kami untuk saham Getinge mencakup kalkulasi keuangan penting seperti pendapatan, keuntungan, P/E ratio (P/E), P/S ratio (P/S), EBIT, serta informasi tentang dividen. Selain itu, kami juga mengamati aspek-aspek seperti saham, kapitalisasi pasar, utang, ekuitas, dan kewajiban dari Getinge. Jika Anda mencari informasi lebih rinci tentang topik-topik ini, kami menawarkan analisis terperinci di subhalaman kami.